The U.S. Food and Drug Administration approved the Pfizer-BioNTech COVID-19 vaccine for emergency use in children aged 5 to 11 on Friday, a critical step toward beginning vaccinations for the age group.
Chickasaw Journal E-Edition Delivery
Are you a Chickasaw Journal subscriber? Sign up to view our weekly e-editions each Wednesday with just a click. Itawamba Times E-Edition Delivery
Are you an Itawamba Times subscriber? Sign up to view our weekly e-editions each Wednesday with just a click. Monroe Journal E-Edition Delivery
Are you a Monroe Journal subscriber? Sign up to view our weekly e-editions each Wednesday with just a click. New Albany Gazette E-Edition Delivery
Are you a New Albany Gazette subscriber? Sign up to view our weekly e-editions each Wednesday with just a click. Pontotoc Progress E-Edition Delivery
Are you a Pontotoc Progress subscriber? Sign up to view our weekly e-editions each Wednesday with just a click.